BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25625847)

  • 21. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.
    Xiao W; Wang J; Li H; Xia D; Yu G; Yao W; Yang Y; Xiao H; Lang B; Ma X; Guo X; Guan W; Xu H; Liu J; Zhang X; Ye Z
    BMC Cancer; 2014 Sep; 14():677. PubMed ID: 25234557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
    Gaisa NT
    Pathologe; 2016 Nov; 37(Suppl 2):196-203. PubMed ID: 27613302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
    Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
    Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
    Li CF; Wu WJ; Wu WR; Liao YJ; Chen LR; Huang CN; Li CC; Li WM; Huang HY; Chen YL; Liang SS; Chow NH; Shiue YL
    Oncotarget; 2015 Apr; 6(11):9220-39. PubMed ID: 25940704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
    Tang H; Goldberg E
    J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer.
    Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ
    Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
    Nixdorf S; Grimm MO; Loberg R; Marreiros A; Russell PJ; Pienta KJ; Jackson P
    Cancer Lett; 2004 Nov; 215(2):209-20. PubMed ID: 15488640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.
    Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
    Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1.
    Denard B; Lee C; Ye J
    Elife; 2012 Dec; 1():e00090. PubMed ID: 23256041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
    Mori K; Enokida H; Kagara I; Kawakami K; Chiyomaru T; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Int J Oncol; 2009 Jun; 34(6):1593-602. PubMed ID: 19424577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
    Kitchen MO; Bryan RT; Emes RD; Glossop JR; Luscombe C; Cheng KK; Zeegers MP; James ND; Devall AJ; Mein CA; Gommersall L; Fryer AA; Farrell WE
    Epigenetics; 2016 Mar; 11(3):237-46. PubMed ID: 26929985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.
    Jackson P; Millar D; Kingsley E; Yardley G; Ow K; Clark S; Russell PJ
    Cancer Lett; 2000 Sep; 157(2):169-76. PubMed ID: 10936677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.
    Wu G; Guo Z; Chang X; Kim MS; Nagpal JK; Liu J; Maki JM; Kivirikko KI; Ethier SP; Trink B; Sidransky D
    Cancer Res; 2007 May; 67(9):4123-9. PubMed ID: 17456585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.